Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in \> 90% of cases. However, at the PSA levels which trigger prostate biopsy, often no cancer is found in prostate biopsy specimens. PSA test can be elevated due to reasons other than cancer such as inflammation or natural variation in the level. Investigators plan to treat men with elevated PSA level with over the counter anti-infl

Trial Details

NCT ID
NCT05629494
Phase
PHASE4
Sponsor
Albany Medical College
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Ibuprofen 400 mg, TID
  • PSA test
Locations (sample)
  • Chicago, Illinois, United States|41.85003,-87.65005
  • Albany, New York, United States|42.65258,-73.75623
  • Hershey, Pennsylvania, United States|40.28592,-76.65025

Key Eligibility Criteria

  • Male patients age between 18-80 years old with a screening PSA \> 3 ng/ml being considered for additional diagnostic testing (e.g., MRI, biopsy)
  • Normal digital rectal examination within the past two years. A documented normal digital rectal examination by another physician or advanced practi…
  • No clinical symptoms concerning for acute urinary tract infection (e.g. dysuria, malodorous urine, positive urine culture)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →